GW Pharmaceuticals

(NASDAQ: GWPH)
Healthcare  |  Drug Manufacturers—General
129.80 2.46 1.93%
Stock Price | June 5, 2020, 2:54 p.m.
15 Followers
Bid: 129.28
Ask: 129.7
Prev. Close: 127.34
52 Week Low: 67.98
52 Week High: 182.05
PE Ratio: 106.116667
Dividend Yield: 0.0%

Company Summary

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Weekend Edition 06/01/20

11 Comments
6 days ago

Premium Cannabis Sub-Sector Review - 05/29/20

6 Comments
6 days ago

Premium Cannabis Stocks Review - AM Edition 05/27/20

30 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 05/27/20

2 Comments
1 week ago

Premium Cannabis Stocks Are Rocking Review - AM Edition 05/26/20

2 Comments
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 05/26/20

39 Comments
1 week ago

Premium Cannabis Sub-Sector Review - 05/22/20

1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 05/22/20

15 Comments
2 weeks ago

Premium Cannabis Stocks Review - AM Edition 05/19/20

4 Comments
2 weeks ago

Premium Cannabis Stocks Review - Pre-Market Edition 05/19/20

9 Comments
2 weeks ago